Financials
- Market Capitalization 3.94 B
- Employee 137
- Founded 2017
- CEO N/A
- Website www.tangotx.com
- Headquarter Delaware, United States
- FIGI BBG00WFDDRS0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1493 | RLAY Relay Therapeutics, Inc. - Common Stock | 18.77 USD | -3.35% | -2.04% | +0.48% | +424.30% | 4.11 B USD | ||
| 1508 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.19 USD | -4.73% | -1.72% | +13.47% | +45.94% | 4.02 B USD | ||
| 1532 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +76.43% | +277.61% | 3.87 B USD | ||
| 1533 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.11 USD | -3.97% | +1.08% | +12.99% | +23.11% | 3.87 B USD |
Frequently asked questions about Tango Therapeutics, Inc.
What is the Tango Therapeutics, Inc. stock price today?
The current price of Tango Therapeutics, Inc. (TNGX) is 23.34. Over the past 24 hours, the stock has changed by -7.67%. Follow the TNGX chart for real-time price dynamics.
What is the stock ticker of Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. trades under the ticker TNGX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Tango Therapeutics, Inc. stock going up?
TNGX has changed by -1.10% over the last week, -11.46% over the last month, and +253.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. currently has a market capitalization of 3.94 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Tango Therapeutics, Inc. earnings last quarter?
Last quarter, Tango Therapeutics, Inc. reported earnings of -0.37 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Tango Therapeutics, Inc. revenue for the last quarter?
Tango Therapeutics, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Tango Therapeutics, Inc. net income for the last quarter?
Tango Therapeutics, Inc. reported net income of -55.34 M for the last quarter. The previous quarter showed -45.51 M, which means net income changed by -21.59%.
How many employees does Tango Therapeutics, Inc. have?
As of the latest available data, Tango Therapeutics, Inc. has 137 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Tango Therapeutics, Inc. stock?
You can buy Tango Therapeutics, Inc. (TNGX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Tango Therapeutics, Inc. stock?
Investing in Tango Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TNGX chart and related analysis on metatrader.com as part of your research.